Literature DB >> 8297199

Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia.

M A Denke1, S M Grundy.   

Abstract

BACKGROUND: Dietary modification is the recommended first step in the treatment of hypercholesterolemia. However, the efficacy of the National Cholesterol Education Program Step 1 Diet in outpatients with hypercholesterolemia has been debated.
METHODS: Fifty normotriglyceridemic men whose ad libitum low-density lipoprotein (LDL) cholesterol levels were 4.14 to 5.69 mmol/L (160 to 220 mg/dL) participated in a two-period outpatient diet counseling study that used a 1-month high-fat, high-saturated fatty acid period (Hi-Sat) and a 4-month low-fat, low-saturated fatty acid period (Step 1 Diet). Lipid, lipoprotein levels, and plasma triglyceride fatty acids were measured five times during the last 2 weeks of each dietary period and averaged for each patient. Dietary intake was assessed by 7-day food records. During the Hi-Sat period, an LDL turnover study was done to determine the fractional catabolic rate of LDL.
RESULTS: The mean reduction in total and LDL cholesterol levels achieved by diet was 0.54 mmol/L (21 mg/dL) and 0.39 mmol/L (15 mg/dL), respectively. These responses equaled those predicted from metabolic ward investigations. While dietary responsiveness was normally distributed, there was marked individual variation in response. The mean (+/- SD) for quartiles of LDL responsiveness were +0.41 +/- 0.21 mmol/L (+16 +/- 8 mg/dL), -0.16 +/- 0.13 mmol/L (-6 +/- 5 mg/dL), -0.57 +/- 0.16 mmol/L (-22 +/- 6 mg/dL), and -1.16 +/- 0.26 mmol/L (-45 +/- 10 mg/dL). These differences in response were partially explained by dietary adherence, baseline fractional catabolic rates of LDL, and the change in plasma triglyceride palmitate level.
CONCLUSIONS: The Step 1 Diet is effective in lowering LDL cholesterol levels for many hypercholesterolemic men, and with appropriate counseling, outpatients can achieve results predicted by inpatient metabolic diet studies. Nonetheless, the responsiveness for individuals is highly variable, and this variability is influenced by both compliance and biologic factors. Since many men achieved LDL cholesterol levels low enough to remove the need for drug therapy in primary prevention for coronary heart disease, dietary therapy should remain the initial approach to the treatment of hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8297199

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

1.  Lean Red Meat and Lean White Meat in the NCEP Step I Diet.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-02

Review 2.  Reduced or modified dietary fat for preventing cardiovascular disease.

Authors:  Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen J Moore; George Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

3.  Differential expression of hepatic genes involved in cholesterol homeostasis in high- and low-responding strains of laboratory opossums.

Authors:  Jeannie Chan; Lisa M Donalson; Rampratap S Kushwaha; Sacha Ferdinandusse; Jane F VandeBerg; John L VandeBerg
Journal:  Metabolism       Date:  2008-05       Impact factor: 8.694

Review 4.  Reduced or modified dietary fat for preventing cardiovascular disease.

Authors:  Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen Moore; George Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

5.  Reduction in saturated fat intake for cardiovascular disease.

Authors:  Lee Hooper; Nicole Martin; Oluseyi F Jimoh; Christian Kirk; Eve Foster; Asmaa S Abdelhamid
Journal:  Cochrane Database Syst Rev       Date:  2020-08-21

6.  Reduction in saturated fat intake for cardiovascular disease.

Authors:  Lee Hooper; Nicole Martin; Oluseyi F Jimoh; Christian Kirk; Eve Foster; Asmaa S Abdelhamid
Journal:  Cochrane Database Syst Rev       Date:  2020-05-19

7.  APOE4 Genotype Exerts Greater Benefit in Lowering Plasma Cholesterol and Apolipoprotein B than Wild Type (E3/E3), after Replacement of Dietary Saturated Fats with Low Glycaemic Index Carbohydrates.

Authors:  Bruce A Griffin; Celia G Walker; Susan A Jebb; Carmel Moore; Gary S Frost; Louise Goff; Tom A B Sanders; Fiona Lewis; Margaret Griffin; Rachel Gitau; Julie A Lovegrove
Journal:  Nutrients       Date:  2018-10-17       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.